Humankind Investments LLC Abb Vie Inc. Transaction History

Humankind Investments LLC

$270 Million
Q3 2024

A detailed history of Humankind Investments LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Humankind Investments LLC holds 15,007 shares of ABBV stock, worth $2.64 Million. This represents 1.1% of its overall portfolio holdings.

Number of Shares

15,007

Previous 16,299 7.93%

Holding current value

$2.64 Million

Previous $2.8 Million 6.01%

% of portfolio

1.1%

Previous 0.76%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$163.84 - $199.33 $211,681 - $257,534	-1,292 Reduced 7.93%	15,007 $2.96 Million
Q2 2024 Aug 12, 2024	BUY	$154.79 - $180.76 $337,751 - $394,418	2,182 Added 15.46%	16,299 $2.8 Million
Q1 2024 May 08, 2024	SELL	$159.82 - $182.1 $411,536 - $468,907	-2,575 Reduced 15.43%	14,117 $2.57 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $165,808 - $186,738	1,205 Added 7.78%	16,692 $2.59 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $82,425 - $95,419	-617 Reduced 3.83%	15,487 $2.31 Million
Q2 2023 Aug 09, 2023	BUY	$132.51 - $164.9 $227,254 - $282,803	1,715 Added 11.92%	16,104 $2.17 Million
Q1 2023 Apr 25, 2023	BUY	$144.61 - $166.54 $71,003 - $81,771	491 Added 3.53%	14,389 $2.29 Million
Q4 2022 Jan 26, 2023	SELL	$138.31 - $165.87 $182,707 - $219,114	-1,321 Reduced 8.68%	13,898 $0
Q3 2022 Nov 09, 2022	BUY	$134.21 - $153.93 $425,177 - $487,650	3,168 Added 26.29%	15,219 $2.04 Million
Q2 2022 Aug 05, 2022	BUY	$137.62 - $174.96 $163,767 - $208,202	1,190 Added 10.96%	12,051 $1.85 Million
Q1 2022 May 09, 2022	SELL	$131.98 - $163.75 $275,574 - $341,910	-2,088 Reduced 16.12%	10,861 $1.76 Million
Q4 2021 Mar 21, 2022	BUY	$107.43 - $135.93 $167,590 - $212,050	1,560 Added 13.7%	12,949 $1.75 Million
Q3 2021 Mar 21, 2022	BUY	$106.4 - $120.78 $242,804 - $275,619	2,282 Added 25.06%	11,389 $1.23 Million
Q2 2021 Mar 21, 2022	BUY	$105.21 - $117.21 $330,990 - $368,742	3,146 Added 52.78%	9,107 $1.03 Million
Q1 2021 Mar 21, 2022	BUY	$102.3 - $112.62 $609,810 - $671,327	5,961 New	5,961 $645,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $312B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Humankind Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Humankind Investments LLC with notifications on news.

Account

Humankind Investments LLC Abb Vie Inc. Transaction History